Orchestra BioMed Holdings, Inc. Quarterly Return On Equity in % from Q3 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2022 to Q3 2024.
  • Orchestra BioMed Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was -107 %, a 86.7% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Return On Equity for 2023 was -58.3 %, a 20.4% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -107 -49.7 -86.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -89.3 -32.5 -57.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -70.2 -15.4 -28% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.3 +14.9 +20.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -57.3 +28.8 +33.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -56.8 Apr 1, 2023 Jun 30, 2023
Q1 2023 -54.8 Jan 1, 2023 Mar 31, 2023
Q4 2022 -73.2 Oct 1, 2022 Dec 31, 2022
Q3 2022 -86.1 Jul 1, 2022 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.